IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control
Béatrice Bréart, Katherine Williams, Stellanie Krimm, Tiffany Wong, Brandon D. Kayser, Lifen Wang, Eric Cheng, Mayra Cruz Tleugabulova, Romain Bouziat, Tianshi Lu, Kobe Yuen, Natalie Firmino, Daniel D. Bravo, Juliette Roels, Atish Bhakta, Jack Bevers, Isabelle Lehoux, Alan Gutierrez, Yajun Chestnut, Joanna E. Klementowicz, Teresita L. Arenzana, Ilseyar Akhmetzyanova, Elizabeth Dixon, Min Chen, Kazi Tasneem, Rajbharan Yadav, Hartmut Koeppen, Soyoung Oh, Lélia Delamarre, Haochu Huang, Shion A. Lim, Gerald Nakamura, Jianyong Wang, Chan Gao, Racquel Corpuz, Sören Müller, Nathaniel R. West
Topics & Concepts
Cytotoxic T cellCancer researchCD8BiologyChemistryCell biologyImmunologyGeneticsImmune systemIn vitroCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune Responses